Instil Bio (TIL) Cash from Operations (2020 - 2026)
Instil Bio (TIL) posted quarterly Cash from Operations of 1337000.0 for Q1 2026, up 68.13% year-over-year from 795224.02 in Q1 2025, and up 81.11% quarter-over-quarter from 7076000.0 in Q4 2025.
Instil Bio (TIL) Cash from Operations (2020 - 2026) Analysis & Trends
Instil Bio's Cash from Operations history runs 7 years deep, the most recent figure standing at 1337000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 68.13% year-over-year to 1337000.0; the TTM figure through Mar 2026 stood at 33761000.0 (up 25.8% YoY), while the FY2025 annual figure was 36619000.0, up 34.25% from the prior year.
- Cash from Operations for Q1 2026 stood at 1337000.0, up from 7076000.0 in the prior quarter.
- The five-year high for Cash from Operations was 1337000.0 in Q1 2026, with the low at 55051000.0 in Q1 2022.
- The 5-year median for Cash from Operations is 14426000.0 (2023), against an average of 20932058.82.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations plunged 210.51% in 2022, then soared 70.85% in 2025.
- Instil Bio's Cash from Operations stood at 36976000.0 in 2022, then jumped by 63.81% to 13381000.0 in 2023, then grew by 21.09% to 10559000.0 in 2024, then surged by 32.99% to 7076000.0 in 2025, then soared by 81.11% to 1337000.0 in 2026.
- Business Quant data shows TIL's Cash from Operations at 1337000.0 in Q1 2026, 7076000.0 in Q4 2025, and 10557000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 326.72 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -88.83 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 728.46 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 360.27 Mn |
| 10 | Instil Bio | 50.29 Mn | 50.29 Mn | - | -4.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.64 Mn |
| Jun 30, 2026 | -4.64 Mn |
| Mar 31, 2026 | -1.34 Mn |
| Mar 31, 2026 | -1.34 Mn |
| Dec 31, 2025 | -7.08 Mn |
| Dec 31, 2025 | -7.08 Mn |
| Sep 30, 2025 | -10.56 Mn |
| Sep 30, 2025 | -10.56 Mn |
| Jun 30, 2025 | -14.79 Mn |
| Jun 30, 2025 | -14.79 Mn |
| Mar 31, 2025 | -4.20 Mn |
| Mar 31, 2025 | -4.20 Mn |
| Dec 31, 2024 | -10.56 Mn |
| Dec 31, 2024 | -10.56 Mn |
| Sep 30, 2024 | -20.13 Mn |
| Sep 30, 2024 | -20.13 Mn |
| Jun 30, 2024 | -10.61 Mn |
| Jun 30, 2024 | -10.61 Mn |
| Mar 31, 2024 | -14.39 Mn |
| Mar 31, 2024 | -14.39 Mn |